Contents

Search

clinical coagulation test

Differential diagnosis: - prolonged prothrombin time, normal aPTT - factor VII deficiency - disseminated intravascular coagulation (DIC) - liver disease - vitamin K deficiency - warfarin - normal prothrombin time, prolonged aPTT - factor VIII deficiency - factor IX deficiency - factor XI deficiency - factor XII deficiency - von Wiilibrand's disease (if factor VIII low) - heparin - prolonged prothrombin time, prolonged aPTT - factor V deficiency - factor X deficiency - factor II deficiency - fibrinogen deficiency - severe liver disease - disseminated intravascular coagulation (DIC) - vitamin K deficiency - warfarin toxicity - heparin overdose - normal prothrombin time, normal aPTT - platelet dysfunction (acquired or congenital) - von Willebrand's disease (factor VIII not too low) - scurvy - Ehlers-Danlos syndrome - hereditary hemorrhagic telangiectasia - factor XIII deficiency

Specific

activated protein C (APC) resistance assay argatroban in plasma clotting time coagulation factor assay coagulation factor II inhibitor in plasma coagulation factor IX inhibitor in plasma coagulation factor V inhibitor in plasma coagulation factor VII inhibitor in plasma coagulation factor VIII inhibitor in plasma coagulation factor X inhibitor in plasma; anti-factor Xa heparin assay coagulation factor XI inhibitor in plasma coagulation factor XII inhibitor in plasma coagulation factor XIII inhibitor in plasma coagulation/fibrinolysis assay/screen (viscoelastic clot assessment) factor IX activity in plasma factor IX antigen in plasma factor V activity in plasma factor V antigen in plasma factor VII activity in plasma factor VII antigen in plasma factor VIIa activity in plasma factor VIII activity in plasma factor VIII antigen in plasma factor X activity in plasma factor XI activity in plasma factor XI antigen in plasma factor XII activity in plasma factor XII antigen in plasma factor XIII activity in plasma factor XIII antigen in plasma factor XIII coagulum dissolution in plasma fibrin degradation products in plasma; fibrin split products in plasma (FDP, FSP) fibrin soluble in serum/plasma fibrinogen Ag in plasma fibrinolysis inhibitor in plasma fibrinopeptide A antigen in body fluid fibrinopeptide B in serum heparin cofactor II in plasma heparin-induced platelet aggregation high molecular weight kininogen in plasma (Fitzgerald factor assay) International normalized ratio (INR) kallikrein in plasma LMW heparin in body fluid low molecular weight kininogen in plasma lupus anticoagulant in plasma maximum clot lysis maxium clot firmness partial thromboplastin time (PTT) plasma mixing studies plasminogen activator urokinase type meausurement plasminogen activity (plasmin) in plasma plasminogen antigen in plasma platelet factor 3 in plasma platelet factor 4 Ag in plasma platelet factor 4 in plasma platelet function in blood prekallikrein (Fletcher Factor) in plasma prothrombin antibody in serum/plasma prothrombin fragment 1.2 Ag in serum/plasma prothrombin fragment 1.2 in serum/plasma prothrombin in plasma prothrombin time (PT) PTT circulating inhibitor in plasma serotonin release assay thrombin time (TT) thrombin-antithrombin complex in plasma thromboglobulin in plasma thrombopoietin in plasma tissue thromboplastin inhibition test von Willebrand factor (vWF) multimers in plasma von Willebrand factor (vWF)-cleaving protease (ADAMTS-13) in plasma von Willebrand factor activity in plasma von Willebrand factor antigen in plasma von Willebrand factor collagen-binding ratio

General

clinical hematology test

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018